| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Pluristem Therapeutics Inc (TA: PSTI)
PSTI Technical Analysis
3
| As on 15th Jul 2025 PSTI SHARE Price closed @ 1706.00 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1652.38 & Buy for SHORT-TERM with Stoploss of 584.81 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PSTISHARE Price
| Open | 1763.00 | Change | Price | % |
| High | 1763.00 | 1 Day | -71.00 | -4.00 |
| Low | 1677.00 | 1 Week | -194.00 | -10.21 |
| Close | 1706.00 | 1 Month | 91.00 | 5.63 |
| Volume | 4492 | 1 Year | 1500.70 | 730.98 |
| 52 Week High 2904.00 | 52 Week Low 203.60 | ||||
TA Israel Most Active Stocks
| TA125 | 2008.05 | 1.06% |
| CANF | 1.20 | -7.69% |
| ORL | 94.10 | 1.84% |
| BEZQ | 630.00 | 3.03% |
| GNRS | 105.50 | 2.43% |
| MGDL | 998.50 | 1.76% |
| MVNE | 1320.00 | -0.08% |
| IBLD | 1320.00 | -0.08% |
| LUMI | 6166.00 | 1.00% |
| DSCT | 3298.00 | 0.55% |
TA Israel Top Gainers Stocks
TA Israel Top Losers Stocks
| PSTI Daily Charts |
PSTI Intraday Charts |
Whats New @ Bazaartrend |
PSTI Free Analysis |
|
|
PSTI Important Levels Intraday
| RESISTANCE | 1871.72 |
| RESISTANCE | 1818.57 |
| RESISTANCE | 1785.72 |
| RESISTANCE | 1752.87 |
| SUPPORT | 1659.13 |
| SUPPORT | 1626.28 |
| SUPPORT | 1593.43 |
| SUPPORT | 1540.28 |
PSTI Forecast July 2025
| 4th UP Forecast | 1933.19 |
| 3rd UP Forecast | 1860.33 |
| 2nd UP Forecast | 1815.29 |
| 1st UP Forecast | 1770.26 |
| 1st DOWN Forecast | 1641.74 |
| 2nd DOWN Forecast | 1596.71 |
| 3rd DOWN Forecast | 1551.67 |
| 4th DOWN Forecast | 1478.81 |
PSTI Weekly Forecast
| 4th UP Forecast | 1880.78 |
| 3rd UP Forecast | 1824.73 |
| 2nd UP Forecast | 1790.08 |
| 1st UP Forecast | 1755.43 |
| 1st DOWN Forecast | 1656.57 |
| 2nd DOWN Forecast | 1621.92 |
| 3rd DOWN Forecast | 1587.27 |
| 4th DOWN Forecast | 1531.22 |
PSTI Forecast2025
| 4th UP Forecast | 7017.58 |
| 3rd UP Forecast | 5314.13 |
| 2nd UP Forecast | 4261.18 |
| 1st UP Forecast | 3208.24 |
| 1st DOWN Forecast | 203.76 |
| 2nd DOWN Forecast | -849.18 |
| 3rd DOWN Forecast | -1902.13 |
| 4th DOWN Forecast | -3605.58 |
Pluristem Therapeutics Inc ( TA Israel Symbol : PSTI )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PSTI Business Profile
Pluristem Therapeutics Inc. operates as a bio-technology company. It focuses on the research, development, clinical trial, and manufacture of cell therapeutic products and related technologies for the treatment of various ischemic, inflammatory, and hematologic conditions, as well as autoimmune disorders. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trial for the recovery after surgery for hip fracture; in Phase II clinical trail for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of steroid-refractory graft versus host disease. It also develops PLX-R18, which has completed Phase I clinical trial incomplete hematopoietic recovery following hematopoietic cell transplantation, as well as conducts various animal studies for the evaluation of PLX-R18 for the treatment of acute radiation syndrome. The company has a license agreement for conducting clinical trials of PLX-PAD product in South Korea. It also has a collaborative project nTRACK, that examines gold nano particles labeling of stem cells; and has collaboration agreement with the NASA's Ames Research Center to evaluate the potential of PLX cell therapies in preventing and treating medical conditions caused during space missions. Pluristem Therapeutics Inc. was incorporated in 2001 and is based in Haifa, Israel. Address: Building No. 5, Haifa, Israel, 3508409
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service